The Influence of Hydro-Alcoholic Media on Drug Release - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

The Influence of Hydro-Alcoholic Media on Drug Release
The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.

Pharmaceutical Technology
Volume 35, Issue 7, pp. 50-58

26. H.M. Fadda, M.A.M Mohamed, and A.W. Basit, Int. J. Pharm. 360 (1-2) 171–176 (2008).

27. M. Walden et al., Drug. Dev. Ind. Pharm. 33 (10) 1101–1111 (2007).

28. J. Koziara, J. So, and N. Agarwal, presentation at the AAPS Annual Meeting and Exposition (San Antonio, TX, 2006).

29. M. Roberts et al., Int. J. Pharm. 332 (1-2) 31–37 (2007).

30. M.J. Traynor et al., Drug. Dev. Ind. Pharm. 34 (8) 885–889 (2008).

31. S. Missaghi, K.A. Fegely, and A.R. Rajabi-Siahboomi, AAPS. PharmSci. 10 (1) 77–80 (2009).

32. B. Ager et al., presentation at the 36th Annual Meeting & Exposition of the Controlled Release Society (Copenhagen, Denmark, 2009).

33. J.E.F. Reynolds, K. Parfitt, A.V. Parsons, S.C. Sweetman, Eds., Martindale, The Extra Pharmacopoeia, 29th ed. (Pharmaceutical Press, London, UK, 1989).

34. A.C. Moffat, M.D. Osselton, and B. Widdop, Eds., Clarke's Analysis of Drugs and Poisons, Vol. 2 (Pharmaceutical Press, London, 2004).

35. N. Seedher, and M. Kanojia, Pharm. Dev. Technol. 14 (2) 185–192 (2009).

36. F.E. Bailey Jr. and J.V. Koleski, Poly(ethy1ene oxide), Chapter 5 (Academic Press, New York, 1976) p. 87.

37. Colorcon "HyperStart services," (2010).

38. FDA, "The Influence of Hydrophilic Pore Formers on Dipyridamole Release from Aqueous Ethylcellulose Film-Coated Pellets," Fed. Regist., 60 (230) p.61642 (1995).

39. P.L. Ritger, and N.A. Peppas, J. Control. Release. 5 (1) 23–36 (1987).

40. P.L. Ritger and N.A. Peppas, J. Control. Release. 5 (1) 37–42 (1987).

41. R. Espinoza, E. Hong, and L. Villafuerte, Int. J. Pharm. 201 (2) 165–173 (2000).

42. J.L. Ford et al., Int. J. Pharm. 71 (1-2) 95–104 (1991).

43. N.K. Ebube et al., Int. J. Pharm. 156 (1) 49–57 (1997).

44. N.K. Ebube et al., Pharm. Dev. Technol. 2 (2) 161–170 (1997).

45. K. Tahara, K. Yamamoto, and T. Nishihata, J. Control. Release. 35 (1) 59–66 (1995).

46. N. Kavanagh and O.I. Corrigan, Int. J. Pharm. 279 (1-2) 141–152 (2004).

47. S.P. Panomsuk et al., Chem. Pharm. Bull. 44 (5) 1039–1042 (1996).

48. J.C. Bode and C. Bode, Alcohol Malnutrition and the Gastrointestinal Tract, in: Nutrition and Alcohol, R.R. Watson, B. Watzl, Eds. (CRC Press, Boca Raton, FL, 1992) pp. 403–428.

49. C. Bode, J.C. Bode, Alcohol. Health. Res. W. 21 (1) 76–83 (1997).

50. A.F. Brown, D.S. Jones, and A.D. Woolfson, supplement to J. Pharm. Pharmacol. 50 157 (1998).

51. D.S. Jones et al., presentation at the AAPS Annual Meeting and Exposition (Toronto, ON, Canada, 2002).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here